H. Hoyer-Kuhn

发表

Sekundäre Formen der Osteoporose

C. Stark, E. Schoenau, O. Semler, 2014, Zeitschrift für Rheumatologie.

Low serum 25-hydroxyvitamin D levels and secondary hyperparathyroidism in Fontan patients

N. Sreeram, F. U. T. Udink Ten Cate, H. Hoyer-Kuhn, 2015, Cardiology in the Young.

Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry

H. Dörr, T. Rohrer, A. Huebner, 2021, Endocrine connections.

Vitamin B6 in primary hyperoxaluria I: first prospective trial after 40 years of practice.

B. Hero, B. Hoppe, R. Volland, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Growth response to growth hormone treatment in patients with SHOX deficiency can be predicted by the Cologne prediction model

E. Schoenau, W. Blum, J. Franklin, 2017, Journal of pediatric endocrinology & metabolism : JPEM.

Comparison of DXA Scans and Conventional X-rays for Spine Morphometry and Bone Age Determination in Children.

M. Hellmich, E. Schoenau, O. Semler, 2016, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Hyperosteoidosis and Hypermineralization in the Same Bone: Bone Tissue Analyses in a Boy with a Homozygous BMP1 Mutation

F. Rauch, E. Schoenau, P. Roschger, 2013, Calcified Tissue International.

Pharmacotherapy in Rare Skeletal Diseases.

E. Schönau, H. Hoyer-Kuhn, H. Hoyer‐Kuhn, 2020, Handbook of experimental pharmacology.

Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI

E. Schoenau, O. Semler, F. Koerber, 2014, Orphanet Journal of Rare Diseases.

Complex lipid globules in early-life nutrition improve long-term metabolic phenotype in intra-uterine growth-restricted rats

M. Rauh, J. Dötsch, A. Oosting, 2018, British Journal of Nutrition.

Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases

O. Semler, Nava Mehdiani, H. Hoyer-Kuhn, 2019, Pediatric Drugs.

Mutations in SEC24D, encoding a component of the COPII machinery, cause a syndromic form of osteogenesis imperfecta.

S. Bohlander, K. Kagan, Filippo Beleggia, 2015, American journal of human genetics.

Letter to the Editor: "The Effect of Whole Body Vibration Training on Bone and Muscle Function in Children With Osteogenesis Imperfecta".

E. Schoenau, O. Semler, H. Hoyer-Kuhn, 2017, The Journal of clinical endocrinology and metabolism.

Diagnostik und Therapie der Osteogenesis imperfecta

H. Hoyer-Kuhn, R. Stücker, J. Wolf, 2017, Monatsschrift Kinderheilkunde.

Vibration-Assisted Home Training Program for Children With Spinal Muscular Atrophy

C. Stark, E. Schoenau, S. Çırak, 2018, Child neurology open.

Correlation of Bone Mineral Density on Quality of Life in Patients with Osteogenesis Imperfecta during Treatment with Denosumab.

C. Stark, E. Schoenau, J. Franklin, 2017, Pediatric Endocrinology Reviews: diabetes, nutrition, metabolism.

Osteogenesis imperfecta: pathophysiology and treatment

O. Semler, C. Netzer, H. Hoyer-Kuhn, 2015, Wiener Medizinische Wochenschrift.

Personalized medicine in patients with Osteogenesis imperfecta

E. Schoenau, O. Semler, J. Doetsch, 2014, Molecular and Cellular Pediatrics.

First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI.

P. Eysel, E. Schoenau, O. Semler, 2012, Journal of musculoskeletal & neuronal interactions.

TBS as a Tool to Differentiate the Impact of Antiresorptives onCortical and Trabecular Bone in Children With OsteogenesisImperfecta.

R. Winzenrieth, E. Schoenau, O. Semler, 2019, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Hyperoxaluria and systemic oxalosis: an update on current therapy and future directions

B. Hoppe, B. Beck, H. Hoyer-Kuhn, 2013, Expert opinion on investigational drugs.

Early vibration assisted physiotherapy in toddlers with cerebral palsy – a randomized controlled pilot trial

M. Hadders‐Algra, B. Hero, C. Stark, 2016, Journal of musculoskeletal & neuronal interactions.

Safety and efficacy of denosumab in children with osteogenesis imperfecta - a first prospective trial

B. Hero, P. Eysel, E. Schoenau, 2016, Journal of musculoskeletal & neuronal interactions.

Neuromuscular training based on whole body vibration in children with spina bifida: a retrospective analysis of a new physiotherapy treatment program

C. Stark, E. Schoenau, O. Semler, 2015, Child's Nervous System.

Individualized treatment with denosumab in children with osteogenesis imperfecta – follow up of a trial cohort

E. Schoenau, O. Semler, C. Netzer, 2019, Orphanet Journal of Rare Diseases.

Primary hyperoxaluria – An update

B. Hoppe, B. Beck, H. Hoyer-Kuhn, 2014, Journal of Pediatric Biochemistry.

Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2.

G. Pals, Q. Waisfisz, H. Meijers-Heijboer, 2020, American journal of human genetics.

Bone Microarchitecture Assessed by Trabecular Bone Score Is Independent of Mobility Level or Height in Pediatric Patients with Cerebral Palsy

R. Winzenrieth, E. Schoenau, O. Semler, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A specialized rehabilitation approach improves mobility in children with osteogenesis imperfecta.

C. Stark, E. Schoenau, O. Semler, 2014, Journal of musculoskeletal & neuronal interactions.

[Secondary forms of osteoporosis. Special features of diagnostics in childhood and adolescence].

C. Stark, E. Schoenau, O. Semler, 2014, Zeitschrift fur Rheumatologie.

Effect of denosumab on the growing skeleton in osteogenesis imperfecta.

E. Schoenau, O. Semler, H. Hoyer-Kuhn, 2014, The Journal of clinical endocrinology and metabolism.

Children with severe Osteogenesis imperfecta and short stature present on average with normal IGF-I and IGFBP-3 levels

E. Schoenau, O. Semler, H. Hoyer-Kuhn, 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[Recommendations for the healthcare of patients with FOP].

D. Banholzer, O. Semler, H. Siggelkow, 2023, Orthopadie.

Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings

J. Adachi, L. Ward, H. Hoyer-Kuhn, 2018, Acta paediatrica.

A Nonclassical IFITM5 Mutation Located in the Coding Region Causes Severe Osteogenesis Imperfecta With Prenatal Onset

B. Wollnik, E. Schoenau, L. Garbes, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Hyperosteoidosis and Hypermineralization in the Same Bone: Bone Tissue Analyses in a Boy with a Homozygous BMP1 Mutation

F. Rauch, E. Schoenau, P. Roschger, 2013, Calcified Tissue International.